NSEOutcome of Board Meeting2d ago · 18 Aug 2026, 12:07 pm
Outcome of Board Meeting
Beta Drugs Limited · BETA
✦ AI SummaryBonus/Split
Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026, where the board of directors approved the allotment of 35,383 Bonus Equity Shares to the holders of Compulsorily Convertible Debentures (CCDs).
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026.
Attachments (1)
📄pdf
Download →
BETA_18082026120648_outcome_of_board_meeting.pdf
View document text
BDL/PKL/SEC/2026-27
18TH August, 2026
National Stock Exchange of India Limited
Exchange Plaza
Bandra Kurla Complex
Bandra East
Mumbai 400051
SYMBOL:- BETA
Dear Sir,
Subject: Outcome of meeting of the board of directors of Beta Drugs Limited (“Company”) under Regulation 30 of
the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 (“SEBI LODR”).
Dear Sir/Madam
Pursuant to Regulation 30 of the Listing Regulations, we wish to inform you that the board of directors of the
Company (“Board”) at its meeting held today i.e., 18th August, 2026, has, inter alia, approved the following
decisions:-
a) the allotment of 35,383 Bonus Equity Shares of face value of INR 10 each to the holders of Compulsorily
Convertible Debentures (CCDs), pursuant to the conversion of such CCDs into Equity Shares.
The meeting of the Board commenced at 11:00 a.m. and concluded at 11:56 a.m.
You are requested to take the same on your record.
Thanking You
Your’s faithfully
For Beta Drugs Ltd.
Rajni Brar
Company Secretary